The H2020 funded Eurostars project BUTTERFLY (E! 12979) is well off and in full speed ahead.
This week we had a
joint meeting with the collaborating partners SpiroChem and Saverna Therapeutics in Basel in Schweiz. We had a day
of good scientific discussions regarding miRNA regulation of autoimmune disease and are looking forward to the
continuation of the project.
Marjo Götte (Saverna), Ingrid Yao Mattisson (Redoxis) and Malin Hopkins (Redoxis) representing the
biology team within the consortium.